Kaat Durinck

1.7k total citations
26 papers, 548 citations indexed

About

Kaat Durinck is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Kaat Durinck has authored 26 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Neurology and 8 papers in Cancer Research. Recurrent topics in Kaat Durinck's work include Neuroblastoma Research and Treatments (9 papers), RNA modifications and cancer (6 papers) and Lung Cancer Research Studies (4 papers). Kaat Durinck is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), RNA modifications and cancer (6 papers) and Lung Cancer Research Studies (4 papers). Kaat Durinck collaborates with scholars based in Belgium, United States and France. Kaat Durinck's co-authors include Frank Speleman, Pieter Van Vlierberghe, Annelynn Wallaert, Tom Taghon, Wouter Van Loocke, Pieter Rondou, Bruce Poppe, Jan Cools, Frank Speleman and Ellen Geerdens and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Kaat Durinck

24 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaat Durinck Belgium 13 335 178 111 101 98 26 548
Wouter Van Loocke Belgium 14 309 0.9× 153 0.9× 97 0.9× 149 1.5× 103 1.1× 21 518
Barbara Szymanska Australia 6 306 0.9× 77 0.4× 155 1.4× 75 0.7× 125 1.3× 7 499
Agnieszka A. Wendorff United States 6 446 1.3× 114 0.6× 139 1.3× 100 1.0× 179 1.8× 8 642
Luyao Xu China 5 628 1.9× 151 0.8× 181 1.6× 92 0.9× 228 2.3× 14 869
Ingrid M. Ariës Netherlands 7 317 0.9× 112 0.6× 95 0.9× 193 1.9× 85 0.9× 9 494
Corrado Caslini United States 14 746 2.2× 99 0.6× 136 1.2× 42 0.4× 229 2.3× 20 937
Wendy L. See United States 9 326 1.0× 121 0.7× 47 0.4× 35 0.3× 248 2.5× 20 557
Andrew L. Wolfe United States 11 689 2.1× 401 2.3× 84 0.8× 92 0.9× 69 0.7× 21 916
Liliana H. Mochmann Germany 10 278 0.8× 50 0.3× 65 0.6× 51 0.5× 155 1.6× 14 436
Ashwini Yenamandra United States 9 363 1.1× 65 0.4× 30 0.3× 37 0.4× 100 1.0× 21 523

Countries citing papers authored by Kaat Durinck

Since Specialization
Citations

This map shows the geographic impact of Kaat Durinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaat Durinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaat Durinck more than expected).

Fields of papers citing papers by Kaat Durinck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaat Durinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaat Durinck. The network helps show where Kaat Durinck may publish in the future.

Co-authorship network of co-authors of Kaat Durinck

This figure shows the co-authorship network connecting the top 25 collaborators of Kaat Durinck. A scholar is included among the top collaborators of Kaat Durinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaat Durinck. Kaat Durinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermeulen, An, Kimberley E. Wever, M. Emmy M. Dolman, et al.. (2025). Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in Neuroblastoma. Journal of Medicinal Chemistry. 68(22). 23962–23976.
2.
Matthijssens, Filip, Béatrice Lintermans, Igor Fijałkowski, et al.. (2024). A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia. Science Advances. 10(44). eado6765–eado6765. 3 indexed citations
3.
Durinck, Kaat & Meredith S. Irwin. (2024). DNA repair and replicative stress addiction in neuroblastoma. SHILAP Revista de lepidopterología. 4. 100177–100177.
4.
Anckaert, Jasper, Fanny De Vloed, Kaat Durinck, et al.. (2024). HTSplotter: An end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening. PLoS ONE. 19(1). e0296322–e0296322. 2 indexed citations
5.
Anckaert, Jasper, Anneleen Decock, Kaat Durinck, et al.. (2023). Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
6.
Vloed, Fanny De, Martijn Risseeuw, Jan J. Molenaar, et al.. (2022). Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma. European Journal of Medicinal Chemistry. 247. 115033–115033. 23 indexed citations
7.
Decaesteker, Bieke, Kaat Durinck, Nadine Van Roy, et al.. (2021). From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. Journal of Personalized Medicine. 11(12). 1286–1286. 2 indexed citations
8.
Zimmerman, Mark W., Nina Weichert‐Leahey, Belamy B. Cheung, et al.. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 13(19). 4783–4783. 9 indexed citations
9.
Vanhauwaert, Suzanne, Christophe Van Neste, Volodimir Olexiouk, et al.. (2021). MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells. Scientific Reports. 11(1). 14454–14454. 8 indexed citations
10.
Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations
11.
Loontiens, Siebe, Inge Van de Walle, Finola E. Moore, et al.. (2020). PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation. Frontiers in Cell and Developmental Biology. 8. 599472–599472. 5 indexed citations
12.
Loontiens, Siebe, Suzanne Vanhauwaert, Charlotte Gistelinck, et al.. (2019). Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposes. BMC Genomics. 20(1). 228–228. 7 indexed citations
13.
Vanhauwaert, Suzanne, Bieke Decaesteker, Sara De Brouwer, et al.. (2018). In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors. Scientific Reports. 8(1). 17468–17468. 7 indexed citations
14.
Wallaert, Annelynn, Kaat Durinck, Tom Taghon, Pieter Van Vlierberghe, & Frank Speleman. (2017). T-ALL and thymocytes: a message of noncoding RNAs. Journal of Hematology & Oncology. 10(1). 66–66. 26 indexed citations
15.
Walle, Inge Van de, Kaat Durinck, Katrien De Mulder, et al.. (2016). GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate. Nature Communications. 7(1). 11171–11171. 49 indexed citations
16.
Durinck, Kaat, Wouter Van Loocke, Joni Van der Meulen, et al.. (2015). Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Leukemia. 29(12). 2317–2327. 19 indexed citations
17.
Durinck, Kaat, Annelynn Wallaert, Inge Van de Walle, et al.. (2014). The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica. 99(12). 1808–1816. 40 indexed citations
18.
Wallaert, Annelynn, Kaat Durinck, Pieter Rondou, et al.. (2014). The NOTCH1 Driven Long Non-Coding RNA Repertoire in T-Cell Acute Lymphoblastic Leukemia. Blood. 124(21). 900–900. 1 indexed citations
19.
Zwaenepoel, Olivier, Abel Garcia‐Pino, Kaat Durinck, et al.. (2014). A nanobody modulates the p53 transcriptional program without perturbing its functional architecture. Nucleic Acids Research. 42(20). 12928–12938. 31 indexed citations
20.
Atak, Zeynep Kalender, Valentina Gianfelici, Gert Hulselmans, et al.. (2013). Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia. PLoS Genetics. 9(12). e1003997–e1003997. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wouter Van Loocke Breakdown of academic impact, for papers by Barbara Szymanska Breakdown of academic impact, for papers by Agnieszka A. Wendorff Breakdown of academic impact, for papers by Luyao Xu Breakdown of academic impact, for papers by Ingrid M. Ariës Breakdown of academic impact, for papers by Corrado Caslini Breakdown of academic impact, for papers by Wendy L. See Breakdown of academic impact, for papers by Andrew L. Wolfe Breakdown of academic impact, for papers by Liliana H. Mochmann Breakdown of academic impact, for papers by Ashwini Yenamandra
Rankless by CCL
2026